- Pharmaceutical companies
- Pierre Fabre
Pierre Fabre
Phone: +33 1 53 53 20 50
Web: https://www.pierre-fabre.com
| Type | Private limited company |
|---|---|
| Industry | Pharmaceutical |
| Founded | 1951 (1951) |
| Headquarters | Paris, France |
| Area served | Worldwide |
| Key people |
|
| Number of employees | 13,000 (2015) (Homepage) |
| Website | www.pierre-fabre.com |
The Pierre Fabre Group is a pioneer on the French industrial scene. Why? A Foundation of the same name, recognized as being of public interest, has been the main Group shareholder since 2013. This unique shareholding structure guarantees the company's independence and helps us favor the longterm over the short term, in line with our founder's principles.
For detailed contact information visit location pages below.
Pierre Fabre's locations around the world
Europe
North America
Oceania
Clinical Trials sponsored by Pierre Fabre
-
Pierre Fabre MedicamentPierre Fabre Pharma GmbHValmis
-
Pierre Fabre Medical DevicesValmis
-
Pierre Fabre Pharma GmbHPierre Fabre Pharma Austria; Pierre Fabre Pharma AGRekrytointiMelanooma vaihe IV | Melanooma vaihe IIIItävalta, Saksa, Sveitsi
-
Pierre Fabre MedicamentRekrytointiEi-pienisoluinen keuhkosyöpä (NSCLC)Taiwan, Espanja, Ranska, Alankomaat, Kiina, Yhdysvallat, Saksa
-
Pierre Fabre MedicamentValmisMetastaattinen melanooma | Melanooma (iho) | BRAF V600 -mutaatioPortugali
-
Pierre Fabre MedicamentValmis
-
Pierre Fabre MedicamentLopetettuPitkälle edenneet tai metastaattiset kiinteät kasvaimetRanska, Espanja
-
Pierre Fabre MedicamentValmisRintasyöpä | MetastaassejaRanska, Ukraina, Yhdistynyt kuningaskunta, Saksa, Taiwan, Espanja, Valko-Venäjä, Belgia, Portugali, Etelä-Afrikka, Venäjän federaatio, Itävalta, Italia, Argentiina
-
Pierre Fabre MedicamentValmis